Jump to Navigation Jump to Content
Home
  • Facebook
  • Twitter
  • YouTube
  • Home
  • Français
  • Contact Us
Centre de distribution de CATIE
  • Hepatitis C
  • Subscriptions
  • Become a Member
Home » Treatment » Treatment Update » TreatmentUpdate 208
  • The Basics
  • Prevention
  • Treatment
  • Healthy Living
  • Strengthening Programming
  • What's New?
  • About CATIE
  • Website Tour

Treatment

  • TreatmentUpdate
  • HIV Treatments
  • Hepatitis C Treatments
  • Treating HIV and Hepatitis C Co-infection
  • HIV-related Infections and Other Health Conditions
  • Paying for Treatment

Latest Blog Posts

  • PositiveLite.com: It’s gone, so what next?

  • Learning from Saskatchewan’s HIV emergency

  • Beyond stigma: Challenging STBBI stigma in the classroom

More

TreatmentUpdate
208
  • See all issues of TreatmentUpdate
  • Subscribe

March/April 2015 

  • Print-friendly PDF

Table of Contents

  • Hepatitis C virus
    • Grazoprevir + elbasvir and other emerging drugs
    • Enter ledipasvir
    • Sirius—ledipasvir + sofosbuvir in cases of severe liver injury
    • Using ledipasvir + sofosbuvir when prior treatment with sofosbuvir failed
    • Grading severe liver disease and predicting survival
    • Ledipasvir + sofosbuvir with or without ribavirin in people with liver transplants
    • Solar-1—ledipasvir + sofosbuvir in people with symptoms of severe liver injury
    • Ledipasvir + sofosbuvir with or without ribavirin in compensated cirrhosis
    • Ledipasvir + sofosbuvir in HCV genotype 6—a pilot study
    • Ledipasvir + sofosbuvir in HIV co-infection

News

HepCinfo Update 9.7: Vosevi added to formulary in BC, ON, QC; HCV cure reduces diabetes risk

Symtuza approved in Canada for treatment of HIV

After hepatitis C cure, kidney problems linked to cocaine use

HepCinfo Update 9.6: ON, BC, QC cover treatment regardless liver injury; spontaneous clearance low in HIV coinfected; HCV nearly eliminated in Australian prison

More

CATIE Announces

CATIE webinar: New Canadian HIV PrEP/nPEP guidelines: public health and community perspectives

Wednesday 16 May
1.00 p.m. EDT

CATIE is hiring!
Regional Health Education Coordinator, Quebec

More

Events

27th Annual Canadian Conference on HIV/AIDS Research (CAHR 2018)

Canadian Association for HIV Research (CAHR)
April 26 to 29, 2018
Vancouver, BC

More

New Resources

HIV Testing – I know my HIV status (CATIE)

TreatmentUpdate 226 (CATIE)

8 Questions about PrEP for Guys (CATIE)

Maviret (glecaprevir + pibrentasvir) (CATIE)

More

The CATIE Exchange

Association of Ontario Health Centres (AOHC): Call for proposals

Dalla Lana School of Public Health, University of Toronto: Positive Plus One Research Study

CANAC: Call for abstracts

More

CATIE: Canada's source for HIV and Hepatitis C information

English Footer Menu (Left)

  • Contact Us
  • Donate to CATIE
  • Funders

English Footer Menu (Right)

  • Privacy
  • Disclaimer
  • Permission to Reproduce
  • Disability policy

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.


We comply with the HONcode standard for trustworthy health information: verify here.


Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.

This website is certified by Health On the Net Foundation. Click to verify.